Market Analysis: The market for blood-borne disease diagnostics is driven by the growing need for accurate and rapid testing to prevent and manage these infections. In 2025, the global market for blood transfusion diagnostics is valued at approximately $5.97 billion. This market is expected to grow, with projections reaching around $8.72 billion by 2030, at a compound annual growth rate (CAGR) of about 7.89%. This growth is fueled by increasing blood donations, a rise in surgical procedures, and technological advancements like nucleic acid testing, which can detect diseases earlier. While North America holds the largest market share, the Asia-Pacific region is projected to experience the fastest growth due to rising healthcare investments and a growing population.
